Concepedia

T. Cusick

TC

5

Publications

289

Citations

5

H-Index

2010

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

T. Cusick is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in osteoporosis, bone metabolism, and medicine.

Top concepts

Publications per year

2010–2016

5

Publications

5

Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey

T. Cusick, Charles M Chen, Brenda L Pennypacker et al. · Journal of Bone and Mineral Research · 2011 · 137 citations

Generation and Selection of Novel Fully Human Monoclonal Antibodies That Neutralize Dickkopf-1 (DKK1) Inhibitory Function in Vitro and Increase Bone Mass in Vivo

Helmut Glantschnig, Richard Hampton, Ping Lü et al. · Journal of Biological Chemistry · 2010 · 99 citations · Full text

, , +18

Bone loss in the oestrogen‐depleted rat is not exacerbated by sitagliptin, either alone or in combination with a thiazolidinedione

T. Cusick, James Mu, Brenda L Pennypacker et al. · Diabetes Obesity and Metabolism · 2013 · 24 citations

Effects of long term treatment with high doses of odanacatib on bone mass, bone strength, and remodeling/modeling in newly ovariectomized monkeys

Le T. Duong, Maureen Pickarski, T. Cusick et al. · Bone · 2016 · 19 citations

, , +9

Pharmacodynamic Responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats

John Fisher, Kevin R. Scott, Nan Wei et al. · Bone · 2012 · 10 citations

, , +10

Rows per page

1–5 of 5